Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial. Academic Article uri icon

Overview

publication date

  • January 1, 1991

Research

keywords

  • Antibodies, Monoclonal
  • Neuroblastoma

Identity

Scopus Document Identifier

  • 0026041422

PubMed ID

  • 2068154

Additional Document Info

volume

  • 366